Thus, understanding the molecular mechanisms by which hsa-miR-5586-5p may regulate FOS expression represents a critical area for further research, with potential implications for developing targeted therapeutic strategies in HER2+ breast cancer. Here, ERBB2 is linked to breast carcinoma.